A double-blind randomized comparison of nortriptyline and paroxetine in the treatment of late-life depression: 6-Week outcome

Journal of Clinical Psychiatry

Volumn 60, Issue SUPPL. 20, 1999, Pages 16-20

  Mulsant, Benoit H ^a,b   Pollock, Bruce G ^a   Nebes, Robert D ^a   Miller, Mark D ^a   Little, John T ^a   Stack, Jackie ^a   Houck, Patricia R ^a   Bensasi, Salem ^a   Mazumdar, Sati ^a   Reynolds III, Charles F ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b WPIC ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; BETHANECHOL; CLOMIPRAMINE; FLUOXETINE; LORAZEPAM; NORTRIPTYLINE; PAROXETINE; SERTRALINE;

AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; GERIATRIC CARE; HEART ATRIUM FIBRILLATION; HEART BLOCK; HOSPITALIZATION; HUMAN; INAPPROPRIATE VASOPRESSIN SECRETION; MAJOR CLINICAL STUDY; MALE; MELANCHOLIA; NAUSEA; ORTHOSTATIC HYPOTENSION; OUTCOMES RESEARCH; PRIORITY JOURNAL; URINE RETENTION;

AGE FACTORS; AGE OF ONSET; AGED; AMBULATORY CARE; ANTIDEPRESSIVE AGENTS, TRICYCLIC; DEPRESSIVE DISORDER; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MULTICENTER STUDIES; NORTRIPTYLINE; PAROXETINE; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 0032881146     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Olfson M, Marcus SC, Pincus HA, et al. Antidepressant prescribing practices of outpatient psychiatrists. Arch Gen Psychiatry 1998;55:310-316
2. Ganguli M, Mulsant BH, Richards S, et al. Antidepressant use over time in a rural older adult population: the MoVIES project. J Am Geriatr Soc 1997; 45:1501-1503
3. Mulsant BH, Singhal S, Kunik M. New developments in the treatment of late-life depression. In: Hales RE, Yudovsky SC, eds. Practical Clinical Strategies in Treating Depression and Anxiety Disorders in a Managed Care Environment. Washington, DC: American Psychiatric Press; 1996
4. Reynolds CF, Alexopoulos G, Katz I, et al. Treatment of geriatric mood disorders. Curr Rev Mood Disord 1997;1:189-202
5. Schneider LS. Pharmacologic considerations in the treatment of late-life depression. Am J Geriatr Psychiatry 1996;4(suppl 1):S51-S65
6. Roose SP, Glassman AH, Attia E, et al. Comparative efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholia. Am J Psychiatry 1994;151:1735-1739
7. Nierenberg AA. Treatment of severe depression: is there an efficacy gap between SSRI and TCA antidepressant generations? J Clin Psychiatry 1994;55(9, suppl A):55-61
8. Nebes RD, Pollock BG, Mulsant BH, et al. Low-level serum anticholinergicity as a source of baseline cognitive heterogeneity in geriatric depressed patients. Psychopharmacol Bull 1997;33:715-719
9. Pollock BG, Mulsant BH, Nebes RD, et al. Serum anticholinergicity in older patients treated with paroxetine or nortriptyline. Am J Psychiatry 1998;155:1110-1112
10. Mulsant BH, Stergiou A, Keshavan MS, et al. Schizophrenia in late life: elderly patients admitted to an acute care psychiatric hospital. Schizophr Bull 1993;19:709-721
11. Mulsant BH, Sweet RA, Rifai AH, et al. The use of the Hamilton Rating Scale for Depression in elderly patients with cognitive impairment and physical illness. Am J Geriatr Psychiatry 1994;2:220-229
12. First MB, Gibbon M, Spitzer RL, et al. Structured Clinical Interview for DSM-IV Axis I Disorders SCID I: Clinician Version, Administration Booklet. Washington, DC: American Psychiatric Press; 1997
13. Miller MD, Paradis CF, Houck PR, et al. Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale. Psychiatry Res 1992;41:237-248
14. Lingjaerde O, Ahlfors UG, Bech P et al. The UKU side effect rating scale: a new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand Suppl 1987;334:1-100
15. Molloy DW, Alemayehu E, Roberts R. Reliability of a standardized Mini-Mental State Examination compared with the traditional Mini-Mental State Examination. Am J Psychiatry 1991;148:102-105
16. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994
17. Alexopoulos GS, Meyers BS, Young RC, et al. The course of geriatric depression with "reversible dementia": a controlled study. Am J Psychiatry 1993;150:1693-1699
18. Emery VO, Oxman TE. Update on the dementia spectrum of depression. Am J Psychiatry 1992;149:305-317
19. Mulsant BH, Pollock BG, Nebes RD, et al. Depression in Alzheimer's dementia. In: Heston LL, ed. Progress in Alzheimer's Disease and Similar Conditions. Washington, DC: American Psychiatric Press; 1997
20. Miller MD, Pollock BG, Rifai AH, et al. Longitudinal analysis of nortriptyline side effects in elderly depressed patients. J Geriatr Psychiatry Neurol 1991;4:226-230
21. Rosen J, Pollock BG, Altieri LP, et al. Treatment of nortriptyline's side effects in elderly patients: a double-blind study of bethanechol. Am J Psychiatry 1993;150:1249-1251
22. Danish University Antidepressant Group. Citalopram: clinical effect profile in comparison to clomipramine: a controlled multicenter study. Psychopharmacology (Berl) 1986;90:131-138
23. Danish University Antidepressant Group. Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance but weaker antidepressant effect than clomipramine in a controlled multicenter study. J Affect Disord 1990;18:289-299
24. Nelson JC, Mazure CM, Bowers MB Jr, et al. A preliminary, open study of the combination of fluoxetine and desipramine for rapid treatment of major depression. Arch Gen Psychiatry 1991;48:303-307
25. Weilburg JB, Rosenbaum JF, Biederman J, et al. Fluoxetine added to non-MAOI antidepressants converts nonresponders to responders: a preliminary report. J Clin Psychiatry 1989;50:447-449
26. Schone W, Ludwig M. A double-blind study of paroxetine compared with fluoxetine in geriatric patients with major depression. J Clin Psychopharmacol 1993;13(2, suppl):34S-39S
27. Newhouse PA, Finkel SI, Richter EM. SSRIs in the treatment of depressed outpatients aged 70 years and older. Presented at the 8th Congress of the European College of Neuropsychopharmacology; 1995
28. Tollefson GD, Bosomworth JC, Heiligenstein JH, et al. Fluoxetine Collaborative Study Group. A double-blind, placebo-controlled clinical trial of fluoxetine in geriatric patients with major depression. Int Psychogeriatr 1995;7:89-104
29. Rouillon F. A double blind multicentre study comparing increasing doses of paroxetine (20-50 mg) and clomipramine (50-150 mg) in elderly patients with major depression. Presented at the 5th World Congress of Biological Psychiatry; 1991; Florence, Italy
30. Geretsegger C, Stuppaeck CH, Mair M, et al. Multicenter double-blind study of paroxetine and amitriptyline in elderly depressed inpatients. Psychopharmacology (Berl) 1995;119:277-281
31. Friedhoff AJ, Alpert M, Clary C, et al. Sertraline versus nortriptyline in the depressed elderly. In: New Research Program and Abstracts of the 151st Annual Meeting of the American Psychiatric Association; June 2, 1998; Toronto, Ontario, Canada. Abstract NR334:157